Lilly Foundayo Launches at $149 Self-Pay, $25 Insured; Competes with Novo Wegovy Tablet

Oral GLP-1 Foundayo, approved in early April, launched via LillyDirect, pharmacies, and telehealth. Pricing: $149/month lowest dose self-pay, $25 commercial insurance. Competes against Novo Nordisk Wegovy tablet (600K March prescriptions).